Claris Lifesciences receives EIR from the USFDA

For its manufacturing facility located near Ahmedabad

Claris Lifesciences announced today that it has received the Establishment Inspection Report for its manufacturing facility located near Ahmedabad, wherein the US FDA has concluded that the inspection stands closed and the facility was found to be acceptable.

Powered by Capital Market - Live News